Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Shock, Cardiogenic

n(g),n(g')-dimethyl-l-arginine has been researched along with Shock, Cardiogenic in 2 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.

Research Excerpts

ExcerptRelevanceReference
"Systemic inflammation and elevated circulating levels of the endogenous nitric oxide inhibitor asymmetrical dimethylarginine (ADMA) have been associated with increased risk in cardiogenic shock (CS)."3.77Inflammation and reduced endothelial function in the course of severe acute heart failure. ( Hermansen, SE; How, OJ; Kalstad, T; Myrmel, T, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hermansen, SE1
Kalstad, T1
How, OJ1
Myrmel, T1
Kielstein, JT1
Sydow, K1
Thum, T1

Other Studies

2 other studies available for n(g),n(g')-dimethyl-l-arginine and Shock, Cardiogenic

ArticleYear
Inflammation and reduced endothelial function in the course of severe acute heart failure.
    Translational research : the journal of laboratory and clinical medicine, 2011, Volume: 157, Issue:3

    Topics: Acute Disease; Aged; Aged, 80 and over; Arginine; Biomarkers; Case-Control Studies; Endothelium, Vas

2011
Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
    JAMA, 2007, Sep-05, Volume: 298, Issue:9

    Topics: Arginine; Enzyme Inhibitors; Glomerular Filtration Rate; Humans; Myocardial Infarction; Nitric Oxide

2007